Please assess the completion status of the following clinical trial:

Trial Title: Ezetimibe (SCH 58235) Taken With Either Atorvastatin or Simvastatin in Participants With Familial Hypercholesterolemia (MK-0653-018)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: 6.0

Eligibility Criteria:
Inclusion Criteria:~* With a diagnosis of homozygous familial hypercholesterolemia~* All females must have a negative pregnancy test prior to study entry. Women of child bearing potential must agree to practice an effective barrier method of birth control for the duration of the study, until one month after treatment.~* Postmenopausal women who are receiving postmenopausal hormonal therapy or raloxifene must be maintained on a stable estrogen (ERT), estrogen/progestin (HRT) or raloxifene regimen during the study period. ERT, HRT or raloxifene cannot be changed during study period.~* Must follow prescribed or stricter diet, and demonstrate completion of Diet Diaries~Exclusion Criteria:~* A history of mental instability, drug or alcohol abuse; or have been treated or are being treated for severe psychiatric illness which, in the opinion of the Investigator, may interfere with optimal participation in the study.~* With underlying disease likely to limit life span to less than 1 year.~* Have previously been randomized in any studies examining ezetimibe~* Pregnant or lactating women.~* With known hypersensitivity or any contraindication to statin therapy.

- Gender: ALL
- Minimum Age: 12 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Atorvastatin 80 mg (Type: EXPERIMENTAL): 80 mg atorvastatin taken orally, once daily for 12 weeks
- Ezetimibe + Atorvastatin 40 mg (Type: EXPERIMENTAL): 10 mg ezetimibe and 40 mg atorvastatin taken orally, once daily for 12 weeks
- Ezetimibe + Atorvastatin 80 mg (Type: EXPERIMENTAL): 10 mg ezetimibe and 80 mg atorvastatin taken orally, once daily for 12 weeks
- Simvastatin 80 mg (Type: EXPERIMENTAL): 80 mg simvastatin taken orally, once daily for 12 weeks
- Ezetimibe + Simvastatin 40 mg (Type: EXPERIMENTAL): 10 mg ezetimibe and 40 mg simvastatin taken orally, once daily for 12 weeks
- Ezetimibe + Simvastatin 80 mg (Type: EXPERIMENTAL): 10 mg ezetimibe and 80 mg simvastatin taken orally, once daily for 12 weeks

Based on this trial design, predict the completion outcome and termination type (if applicable).